Home › SEC Filings › Insider Cluster Activity
Insider Cluster Activity
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| QURE | CLUSTER | mixed | 5/10 | uniQure's CEO and CMO sold ~$2.9M in open-market sales within days of a $225M public offering. The sales are modest rela | Jul 2, 2026 |
| RPRX | CLUSTER | neutral | 2/10 | Two EVPs at Royalty Pharma sold a combined $6.01M in open-market sales over a one-week window, representing just 0.02% o | Jul 2, 2026 |
| BEAM | CLUSTER | mixed | 5/10 | A cluster of insider selling at Beam Therapeutics materialized over June 26-30, 2026, totaling $8.95M. The CEO exercised | Jul 2, 2026 |
| MAZE | CLUSTER | neutral | 3/10 | A cluster of insider sales at Maze Therapeutics involving the CEO ($622K) and the head of CSBO ($210K) for a total of $8 | Jul 2, 2026 |
| CADL | CLUSTER | neutral | 2/10 | Two C-suite insiders at Candid Therapeutics sold a combined ~$306K in open-market transactions on June 29, representing | Jul 2, 2026 |
| RAPP | CLUSTER | neutral | 3/10 | CEO Abraham Ceesay and COO Cheryl Gault sold a combined ~$368K worth of RAPP shares in open-market transactions on June | Jul 2, 2026 |
| BEAM | CLUSTER | bearish | 4/10 | CEO John M. Evans exercised options and sold shares worth ~$1.26M, while 10% owner FMR LLC sold 251,488 shares (~$8.87M) | Jul 2, 2026 |
| ZLAB | CLUSTER | neutral | 3/10 | Four Zai Lab insiders, including the CEO, CFO, and Chief Legal Officer, sold a total of ~$667K in open-market sales over | Jul 2, 2026 |
| ROIV | CLUSTER | bearish | 5/10 | Six Roivant insiders, including the President & CIO and the President & Immunovant CEO, sold a total of ~$43.3M in open- | Jul 2, 2026 |
| RVMD | CLUSTER | neutral | 2/10 | Two insiders at Revolution Medicines sold a total of $817K in stock over a 7-day window. CFO Jack Anders sold $762K (4.6 | Jul 2, 2026 |
| PCSA | CLUSTER | bullish | 5/10 | Two C-suite insiders (CFO and President of R&D) made open-market purchases totaling ~$11K on June 30, 2026, at $1.93/sha | Jul 2, 2026 |
| PGEN | CLUSTER | bearish | 5/10 | Three top executives at Precigen (CEO, CFO, COO) sold a combined $2.46M in open-market stock on June 29, 2026, with the | Jul 2, 2026 |
| IBRX | CLUSTER | neutral | 2/10 | Two directors at ImmunityBio sold a combined ~$1.06M in open-market sales over a 7-day window, with the largest sale ($8 | Jul 2, 2026 |
| ORKA | CLUSTER | neutral | 5/10 | { "summary": "A massive insider selling cluster at Oruka Therapeutics: director/10% owner Fairmount Funds Management L | Jul 1, 2026 |
| FTH | CLUSTER | neutral | 3/10 | CEO Anand Parikh and CFO Brian Stephenson made open-market purchases totaling ~$235K over a 10-day window, following the | Jul 1, 2026 |
| CTNM | CLUSTER | neutral | 2/10 | CEO Carmine Stengone and CMO Tim Watkins sold small open-market positions on June 30, 2026, totaling $334K (0.05% of mar | Jul 1, 2026 |
| PHVS | CLUSTER | neutral | 3/10 | Three Pharvaris insiders, the Chief Medical Officer, Chief Early Development Officer, and a Director, sold a total of ~$ | Jul 1, 2026 |
| LXEO | CLUSTER | neutral | 3/10 | Two C-suite insiders (COO and CFO) at Lexeo Therapeutics sold a combined ~$42K in open-market sales on July 1, 2026, imm | Jul 1, 2026 |
| GLUE | CLUSTER | neutral | 2/10 | A cluster of 4 Monte Rosa insiders (CMO, CSO, COO, Director) sold shares totaling $467K over a week, with all sales foll | Jul 1, 2026 |
| NVCT | CLUSTER | bullish | 7/10 | CEO Ron Bentsur and 10% owner Marlio Charles Mosseri made open-market purchases totaling $1.17M on the same day as a $93 | Jul 1, 2026 |
| ROIV | CLUSTER | neutral | 4/10 | Insider cluster at Roivant Sciences shows $32.32M in open-market sales over 7 days, led by President/CIO Sukhatme and la | Jun 30, 2026 |
| UTHR | CLUSTER | neutral | 3/10 | CEO Martine Rothblatt sold ~$6.0M in open-market sales across June 29-30, 2026, alongside derivative exercises at $135.4 | Jun 30, 2026 |
| ADPT | CLUSTER | neutral | 2/10 | Three Adaptive Biotechnologies insiders (a director and both chief commercial officers) sold a total of ~$1.39M in open- | Jun 30, 2026 |
| GALT | CLUSTER | neutral | 3/10 | Two insiders at Galectin Therapeutics (CEO-level CMO and a director) collectively sold $278K worth of GALT stock in a 5- | Jun 30, 2026 |
| DYN | CLUSTER | neutral | 5/10 | Three Dyne Therapeutics insiders sold a combined $5.02M in shares over a 6-day window, led by Director Rhodes ($4.9M). C | Jun 30, 2026 |
| SEPN | CLUSTER | neutral | 2/10 | Two insiders at Septerna sold a total of $357K in shares over a week, representing a trivial 0.02% of the $1.6B market c | Jun 30, 2026 |
| IRON | CLUSTER | neutral | 2/10 | Two C-suite insiders at Disc Medicine (IRON) sold a total of $209K in open-market shares over a 4-day window, all via sa | Jun 30, 2026 |
| IONS | CLUSTER | neutral | 2/10 | Four IONIS executives, including CEO Brett Monia, sold a total of $7.22M in open-market shares over a three-day window. | Jun 30, 2026 |
| VCEL | CLUSTER | neutral | 2/10 | Four Vericel Corp executives sold shares totaling ~$1.14M on June 26, 2026, all coinciding with option exercises. The sa | Jun 30, 2026 |
| CAPR | CLUSTER | neutral | 3/10 | Two C-suite insiders at CAPR (CFO and EVP/General Counsel) exercised stock options and concurrently sold shares in a nea | Jun 29, 2026 |